CN105820124A - Synthesizing method for binimetinib - Google Patents

Synthesizing method for binimetinib Download PDF

Info

Publication number
CN105820124A
CN105820124A CN201610303794.8A CN201610303794A CN105820124A CN 105820124 A CN105820124 A CN 105820124A CN 201610303794 A CN201610303794 A CN 201610303794A CN 105820124 A CN105820124 A CN 105820124A
Authority
CN
China
Prior art keywords
fluoro
tert
buddhist nun
butoxyethoxy
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610303794.8A
Other languages
Chinese (zh)
Other versions
CN105820124B (en
Inventor
陈健
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUNAN OUYA BIOLOGICAL CO Ltd
Original Assignee
HUNAN OUYA BIOLOGICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUNAN OUYA BIOLOGICAL CO Ltd filed Critical HUNAN OUYA BIOLOGICAL CO Ltd
Priority to CN201610303794.8A priority Critical patent/CN105820124B/en
Publication of CN105820124A publication Critical patent/CN105820124A/en
Application granted granted Critical
Publication of CN105820124B publication Critical patent/CN105820124B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2

Abstract

The invention discloses a synthesizing method for binimetinib. The method comprises the steps that 2,3,4-trifluoro-5-nitrobenzoic acid and O-(2-tert-butoxy ethyl)hydroxylamine are subjected to a condensation reaction, and obtained N-(2-tert-butoxy ethyoxyl)-2,3,4-trifluoro-5-nitrobenzamide and ammonium hydroxide are subjected to an ammonolysis reaction; obtained N-(2-tert-butoxy ethyoxyl)-2,4-diamino-3-fluoro-5-nitrobenzamide and formic acid are subjected to a ring-closure reaction in a Pearlman's catalyst; obtained N-(2-tert-butoxy ethyoxyl)-6-amino-7-fluoro-3H-benzimidazole-5-formamide and 4-bromo-2-fluoro-1-iodobenzene are subjected to a substitution reaction; obtained N-(2-tert-butoxy ethyoxyl)-6-[(4-bromo-2-fluoro-phenyl)amino]-7-fluoro-3H-benzimidazole-5-formamide is firstly subjected to a methylation reaction with methyl iodide and then subjected to a deprotection reaction with phosphoric acid, and binimetinib is obtained. The synthesizing method is short in route, operation is simplified, cost is low, and the synthesizing method is environmentally friendly and suitable for industrial production.

Description

A kind of synthetic method replacing Buddhist nun than Buddhist nun
Technical field
The invention belongs to pharmaceutical chemistry synthesis technical field, be specifically related to a kind of anti-cancer agent and replace the synthetic method of Buddhist nun than Buddhist nun.
Background technology
Mitogen activated protein kinase (MEK) inhibitor replaces the chemistry entitled N-(2-of Buddhist nun (Binimetinib, MEK162) than Buddhist nun Hydroxyl-oxethyl)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide, its chemical structural formula is:
The anti-cancer agent researched and developed for Ai Rui biopharmaceutical company of the Ni Shi U.S. (Array Biopharma) than Buddhist nun, for NRAS Gene mutation body melanoma, BRAF gene mutation body melanoma and the treatment of recurrent rudimentary blood plasma ovarian cancer patients, mesh Front clinical three phases test is successful, provides a kind of effective target therapeutic agent to patient, thereby increases and it is possible to for almost without effectively controlling The cancer patient for the treatment of method provides a kind of new therapeutic choice.
A kind of disclosed in patent WO2014063024 prepare than Buddhist nun for the synthetic route of Buddhist nun: with 6-amino-7-fluoro-3-methyl-3H-benzene And imidazole-5-carboxylic acid methyl ester (No. CAS is 918321-20-7) and the bromo-2-of 4-fluoro-1-iodobenzene are initiation material, by condensation, water Solution, amidatioon, last deprotection, obtain than Buddhist nun for Buddhist nun.But 6-amino-7-fluoro-3-methyl-3H-benzimidazole-5-carboxylic acid methyl ester Needing multistep synthetically prepared, patent WO2007002157 has specialized in its syntheti c route, and i.e. with 2,3,4-trifluoro-benzoic acids are Initiation material, obtains this intermediate by 5 or 6 steps, and total process route is as follows:
The disclosed synthetic route replacing Buddhist nun than Buddhist nun of patent WO2013142182, is also with 2, and 3,4-trifluoro-benzoic acids are initiation material, Through nitrification, ammonification, be esterified, be condensed, cyclization, bromination, methylate, hydrolyze, amidatioon, the step such as last deprotection, Obtaining than Buddhist nun for Buddhist nun, process route is as follows:
Above two to be combined into the step of route the longest, and reaction condition and technique are the harshest, complicated, thus complex operation, Relatively costly, it is unfavorable for amplifying production and Industry Promotion, it is therefore necessary to exploration technological process is short, simple to operate, low cost Honest and clean and use the ratio Buddhist nun of the applicable industrialized production synthetic method for Buddhist nun.
Summary of the invention
For the deficiencies in the prior art and defect, it is an object of the invention to provide a kind of synthetic method replacing Buddhist nun than Buddhist nun.
In order to realize foregoing invention purpose, the technical solution used in the present invention is:
Described than Buddhist nun for the synthetic route of Buddhist nun it is
Than specifically comprising the following steps that of the synthetic method that Buddhist nun replaces Buddhist nun
(1) N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide is prepared: by 2,3,4-tri-fluorine-5-nitro benzoic acid In the system that condensing agent, acid binding agent alkali, solvent form, carry out condensation reaction with O-(2-t-butoxy ethyl) azanol, obtain N-(2- Tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide;
(2) N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide is prepared: by N-(2-tert-butoxy second Epoxide)-2,3,4-tri-fluoro-5-nitrobenzamides and ammonia carries out the aminating reaction that pressurizes in N-Methyl pyrrolidone, obtains N-(2- Tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide;
(3) N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide is prepared: by N-(2-tert-butoxy Ethyoxyl)-2,4-diaminourea-3-fluoro-5-nitrobenzamide and formic acid carries out cyclization at palladium dydroxide carbon in the system of solvent composition Reaction, obtains N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide;
(4) N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide is prepared: By N-(2-the tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide fluoro-1-iodobenzene of 2-bromo-with 4-at base reagent, urge The system of agent, complexant and solvent composition carries out substitution reaction, obtains N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorobenzene Base) amino]-7-fluoro-3H-benzimidazole-5-Methanamide;
(5) preparation replaces Buddhist nun than Buddhist nun: by N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole -5-Methanamide carries out methylation reaction at base reagent with iodomethane in the system of solvent composition, obtains N-(tert-butoxy ethoxy Base)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide, then by N-(tert-butoxy ethoxy Base)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide and phosphoric acid carries out deprotection reaction, obtains Than Buddhist nun for Buddhist nun.
Preferably, the condensing agent described in step (1) is N, N '-carbonyl dimidazoles, 1-(3-dimethylamino-propyl)-3-ethyl carbon two Asia Amine, 1-hydroxy benzo triazole, N, N '-dicyclohexylcarbodiimide or N, N '-DIC;Described acid binding agent Alkali is N, N-diisopropylethylamine, triethylamine, diethylamine, trimethylamine, pyridine, piperidines, DMAP, 2,6-bis- Picoline, aniline, N, N-dimethylaniline, N, N-diethylaniline, Tris(isopropylamine)., tri-n-butylamine, tetramethyl guanidine, N-first Base morpholine or N-ethylmorpholine;Described solvent is oxolane, dichloromethane, 1,2-dichloroethanes, chloroform, chlorobenzene, second Nitrile, toluene, N,N-dimethylformamide, methyl tertiary butyl ether(MTBE) or 1,4-dioxane;Wherein, 2,3,4-tri-fluoro-5-Nitrobenzol Mol ratio between formic acid, O-(2-t-butoxy ethyl) azanol, condensing agent, acid binding agent alkali, solvent is 1.0: (1.1~1.5): (1.1~1.8): (3.5~5.5): (10.0~25.0).
Preferably, the mass percent concentration of the ammonia described in step (2) is 28%;Wherein, N-(2-tert-butoxyethoxy)-2,3,4- Mol ratio between three fluoro-5-nitrobenzamides, ammonia, N-Methyl pyrrolidone is 1.0: (5.5~6.5): (5.0~20.0).
Preferably, the noble metal mass percentage content of the palladium dydroxide carbon described in step (3) is 20%;Described solvent is first Alcohol, ethanol, the tert-butyl alcohol or isopropanol;Wherein, N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide, Mol ratio between formic acid, palladium dydroxide carbon, solvent is 1.0: (10~20): (0.5~1.0): (50.0~80.0).
Preferably, the base reagent described in step (4) is cesium carbonate, potassium carbonate or sodium carbonate;Described catalyst is three (two benzal Benzylacetone) two palladiums or double (tri-butyl phosphine) palladium;Described complexant is 4,5-double diphenylphosphine-9,9-dimethyl xanthene, double (2- Diphenylphosphine phenyl) ether or 4,6-bis-(diphenylphosphine) azophenlyene;Described solvent is toluene, 1,4-dioxane or N, N-dimethyl Methanamide;Wherein, N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide, the bromo-2-of 4-fluoro-1-iodobenzene, Mol ratio between base reagent, catalyst, complexant, solvent is 1.0: (1.1~1.4): (2.2~2.8): (0.03~0.05): (0.06~0.1): (10.0~50.0).
Preferably, the base reagent described in step (5) is potassium carbonate, sodium carbonate or cesium carbonate;Described solvent is N, N-dimethyl Methanamide or DMAC N,N' dimethyl acetamide;Wherein, N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino] the fluoro-3H-of-7- Mol ratio between benzimidazole-5-Methanamide, iodomethane, base reagent, solvent is 1.0: (1.1~1.3): (1.4~1.8): (15.0~30.0).
Preferably, the temperature of the condensation reaction described in step (1) is 40~60 DEG C, and the response time is 4~12h;Step (2) institute The pressure of the aminating reaction stated is 2~3 atmospheric pressure, and reaction temperature is 70~90 DEG C, and the response time is 4~8h;Step (3) is described The temperature of ring-closure reaction be 65~100 DEG C, the response time is 16~32h;The temperature of the substitution reaction described in step (4) is 90~110 DEG C, the response time is 8~16h;The temperature of the methylation reaction described in step (5) is 50~75 DEG C, and the response time is 1~4h.
A kind of synthetic method replacing Buddhist nun than Buddhist nun of the present invention, first with 2,3,4-tri-fluorine-5-nitro benzoic acids and O-(2-tertiary fourth oxygen Base ethyl) azanol is raw material, prepares amidatioon midbody compound, carries out aminating reaction and ring-closure reaction the most successively, so After the more fluoro-1-iodobenzene of 2-bromo-with 4-carry out substitution reaction, obtained 5 and 6 substituted benzimidazole parent nucleus knot of target product Structure, simplifies purification and the purity of synthetic route and optimize technological operation, beneficially intermediate, finally by methylation reaction And deprotection, obtain finished product than Buddhist nun for Buddhist nun.
The technical scheme that the present invention provides has following technical effect that one, shortens reactions steps so that technological operation is more The most succinct, the impurity of each step reaction is less, controlled, obtains higher yield;Its two, owing to will not produce in preparation process Raw pollutant, thus environmental protection effect can be embodied;Its three, process route initiation material and the reagent used of the present invention are easy , the use demand meeting crude drug can be produced in a large number, it is adaptable to industrialized production.
In a word, the inventive method process route is reasonable, operation is succinct, reagent is easy to get and total recovery is high and is satisfied industrialization and puts Big production requirement also can embody excellent environmental protection effect.
Detailed description of the invention
Embodiment 1
A) N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide is prepared:
2,3,4-tri-fluorine-5-nitro benzoic acid (25.0g, 0.11mol) and N, N '-carbonyl dimidazoles (22.9g, 0.14mol) are dissolved in four Hydrogen furan (110mL), stirring, add O-(2-t-butoxy ethyl) azanol (18.1g, 0.14mol), drip N, N-diisopropyl Base ethamine (58.5g, 0.45mol), reactant mixture 50 DEG C stirring reaction 8h, TLC point plate determines that reaction is complete, and reactant liquor revolves Steaming is concentrated to dryness, and adds dilute hydrochloric acid and regulates to neutral, adds ethyl acetate extraction, and magnesium sulfate is dried, and concentrated by rotary evaporation is the most dry, first Alcohol recrystallization, obtains the fluoro-5-nitrobenzamide of N-(2-tert-butoxyethoxy)-2,3,4-tri-, off-white color solid (33.5g), yield 88.0%, the reaction equation of this step is as follows:
B) N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide is prepared:
N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide (33.0g, 0.10mol) is dissolved in N-Methyl pyrrolidone (83mL), adding the ammonia (0.59mol) of mass percent concentration 28%, reactant mixture is placed in airtight stainless steel cauldron In at 85 DEG C, stirring reaction 6h under the pressure of 2.5 atmospheric pressure, after completion of the reaction, be cooled to 40 DEG C and delivery systme pressure, slow Slowly add water (40mL), be cooled to 10 DEG C, crystallize 3h, filters, recrystallisation from isopropanol, obtains N-(2-tert-butoxyethoxy)-2,4- Diaminourea-3-fluoro-5-nitrobenzamide, off-white color solid (29.3g), yield 90.5%, the reaction equation of this step is as follows:
C) N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide is prepared:
N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide (29.0g, 0.09mol), formic acid (52.5g, 1.14mol), the palladium dydroxide carbon (28.0g, 0.05mol) of noble metal mass percentage content 20% mixes with ethanol (350mL) Closing, reactant mixture 95 DEG C stirring reaction 16h, TLC point plate determines that reaction is complete, and reactant liquor is down to room temperature, filters, and rotation is steamed It is concentrated to dryness, with ethyl acetate and normal hexane mixed solvent recrystallization, obtains N-(2-tert-butoxyethoxy) the fluoro-3H-of-6-amino-7- Benzimidazole-5-Methanamide, off-white color solid (21.6g), yield 79.3%, the reaction equation of this step is as follows:
D) N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide is prepared:
N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide (21.0g, 0.07mol) is dissolved in toluene (270mL), the bromo-2-of 4-fluoro-1-iodobenzene (24.4g, 0.08mol), cesium carbonate (52.9g, 0.16mol), three (dibenzylidenes are added Acetone) two palladiums (2.2g, 2.4mmol), 4, double diphenylphosphine-9 of 5-, 9-dimethyl xanthene (2.7g, 4.7mmol), reactant mixture 100 DEG C of stirring reaction 12h, TLC point plates determine that reaction is complete, and reactant liquor is down to room temperature, filters, and filtrate concentrated by rotary evaporation is the most dry, With ethyl acetate and normal hexane mixed solvent recrystallization, obtain N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7- Fluoro-3H-benzimidazole-5-Methanamide, off-white color solid (27.0g), yield 82.5%, the reaction equation of this step is as follows:
E) prepare than Buddhist nun for Buddhist nun:
N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide (27.0g, 0.06mol) it is dissolved in DMF (80mL), adds potassium carbonate (12.6g, 0.09mol), be cooled to-10 DEG C, drip Adding iodomethane (9.5g, 0.07mol), reactant mixture 65 DEG C stirring reaction 2h, TLC point plate determines that reaction is complete, reactant liquor Being down to room temperature, concentrated by rotary evaporation, to dry, adds ethyl acetate extraction, and magnesium sulfate is dried, and concentrated by rotary evaporation is the most dry, recrystallizing methanol, Obtain N-(tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide, then By the deprotection reaction step of patent WO2014063024, carry out deprotection reaction with phosphoric acid, through post processing and purification, Than Buddhist nun for Buddhist nun, off-white color solid (13.8g), yield 56.0%, the reaction equation of this step is as follows:
Embodiment 2
A) N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide is prepared:
2,3,4-tri-fluorine-5-nitro benzoic acid (30.0g, 0.14mol) and 1-(3-dimethylamino-propyl)-3-ethyl carbodiimide (27.4g, 0.18mol) it is dissolved in chloroform (240mL), stirring, add O-(2-t-butoxy ethyl) azanol (23.5g, 0.18mol), dropping Triethylamine (61.8g, 0.61mol), reactant mixture 55 DEG C stirring reaction 9h, TLC point plate determines that reaction is complete, and reactant liquor revolves Steaming is concentrated to dryness, and adds dilute hydrochloric acid and regulates to neutral, adds ethyl acetate extraction, and magnesium sulfate is dried, and concentrated by rotary evaporation is the most dry, first Alcohol recrystallization, obtains the fluoro-5-nitrobenzamide of N-(2-tert-butoxyethoxy)-2,3,4-tri-, off-white color solid (39.9g), yield 87.4%, the reaction equation of this step is with embodiment 1;
B) N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide is prepared:
N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide (39.0g, 0.12mol) is dissolved in N-Methyl pyrrolidone (100mL), adding the ammonia (0.74mol) of mass percent concentration 28%, reactant mixture is placed in airtight stainless steel reaction At 80 DEG C, stirring reaction 8h under the pressure of 3 atmospheric pressure in still, after completion of the reaction, it is cooled to 40 DEG C and delivery systme pressure, slow Slowly add water (45mL), be cooled to 10 DEG C, crystallize 3h, filters, recrystallisation from isopropanol, obtains N-(2-tert-butoxyethoxy)-2,4- Diaminourea-3-fluoro-5-nitrobenzamide, off-white color solid (35.4g), yield 92.5%, the same embodiment of reaction equation of this step 1;
C) N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide is prepared:
N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide (35.0g, 0.11mol), formic acid (73.2g, 1.59mol), the palladium dydroxide carbon (39.5g, 0.07mol) of noble metal mass percentage content 20% mixes with methanol (300mL) Closing, reactant mixture 80 DEG C stirring reaction 18h, TLC point plate determines that reaction is complete, and reactant liquor is down to room temperature, filters, and rotation is steamed It is concentrated to dryness, with ethyl acetate and normal hexane mixed solvent recrystallization, obtains N-(2-tert-butoxyethoxy) the fluoro-3H-of-6-amino-7- Benzimidazole-5-Methanamide, off-white color solid (25.3g), yield 77.0%, the reaction equation of this step is with embodiment 1;
D) N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide is prepared:
N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide (25.0g, 0.08mol) is dissolved in 1,4-dioxy Six rings (300mL), add the bromo-2-of 4-fluoro-1-iodobenzene (31.5g, 0.10mol), potassium carbonate (27.8g, 0.20mol), double (three uncles Butyl phosphine) palladium (1.6g, 3.2mmol), double (2-diphenylphosphine phenyl) ether (3.5g, 6.4mol), reactant mixture 95 DEG C stirring is anti- Reaction is complete to answer 14h, TLC point plate to determine, reactant liquor is down to room temperature, filters, and filtrate concentrated by rotary evaporation, to dry, uses ethyl acetate With normal hexane mixed solvent recrystallization, obtain N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzo miaow Azoles-5-Methanamide, off-white color solid (33.1g), yield 84.9%, the reaction equation of this step is with embodiment 1;
E) prepare than Buddhist nun for Buddhist nun:
N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide (33.0g, 0.07mol) it is dissolved in N,N-dimethylacetamide (100mL), adds sodium carbonate (11.6g, 0.11mol), be cooled to-10 DEG C, Dropping iodomethane (12.6g, 0.09mol), reactant mixture 70 DEG C stirring reaction 3h, TLC point plate determines that reaction is complete, reaction Liquid is down to room temperature, and concentrated by rotary evaporation, to dry, adds ethyl acetate extraction, and magnesium sulfate is dried, and concentrated by rotary evaporation is the most dry, recrystallizing methanol, Obtain N-(tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide, then By the deprotection reaction step of patent WO2014063024, carry out deprotection reaction with phosphoric acid, through post processing and purification, Than Buddhist nun for Buddhist nun, off-white color solid (17.3g), yield 57.4%, the reaction equation of this step is with embodiment 1.
Embodiment 3
A) N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide is prepared:
2,3,4-tri-fluorine-5-nitro benzoic acid (32.0g, 0.14mol) and 1-hydroxy benzo triazole (27.4g, 0.20mol) are dissolved in second Nitrile (150mL), stirring, add O-(2-t-butoxy ethyl) azanol (24.1g, 0.18mol), drip DMAP (67.2g, 0.55mol), reactant mixture 60 DEG C stirring reaction 10h, TLC point plate determines that reaction is complete, reactant liquor rotation inspissation Being reduced to do, add dilute hydrochloric acid and regulate to neutral, add ethyl acetate extraction, magnesium sulfate is dried, and concentrated by rotary evaporation is the most dry, methanol weight Crystallization, obtains the fluoro-5-nitrobenzamide of N-(2-tert-butoxyethoxy)-2,3,4-tri-, off-white color solid (41.8g), yield 85.8%, The reaction equation of this step is with embodiment 1;
B) N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide is prepared:
N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide (40.0g, 0.12mol) is dissolved in N-Methyl pyrrolidone (130mL), adding the ammonia (0.69mol) of mass percent concentration 28%, reactant mixture is placed in airtight stainless steel reaction At 90 DEG C, stirring reaction 7h under the pressure of 2 atmospheric pressure in still, after completion of the reaction, it is cooled to 40 DEG C and delivery systme pressure, slow Slowly add water (40mL), be cooled to 10 DEG C, crystallize 3h, filters, recrystallisation from isopropanol, obtains N-(2-tert-butoxyethoxy)-2,4- Diaminourea-3-fluoro-5-nitrobenzamide, off-white color solid (36.0g), yield 91.6%, the same embodiment of reaction equation of this step 1;
C) N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide is prepared:
N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide (36.0g, 0.11mol), formic acid (80.3g, 1.74mol), the palladium dydroxide carbon (46.4g, 0.09mol) of noble metal mass percentage content 20% and the tert-butyl alcohol (550mL) Mixing, reactant mixture 100 DEG C stirring reaction 24h, TLC point plate determines that reaction is complete, and reactant liquor is down to room temperature, filters, rotation Steaming is concentrated to dryness, and with ethyl acetate and normal hexane mixed solvent recrystallization, obtains N-(2-tert-butoxyethoxy) the fluoro-3H-of-6-amino-7- Benzimidazole-5-Methanamide, off-white color solid (26.4g), yield 78.0%, the reaction equation of this step is with embodiment 1;
D) N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide is prepared:
N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide (26.0g, 0.08mol) is dissolved in toluene (330mL), the bromo-2-of 4-fluoro-1-iodobenzene (34.0g, 0.11mol), sodium carbonate (23.1g, 0.22mol), three (dibenzylidenes are added Acetone) two palladiums (3.5g, 3.8mmol), 4,6-bis-(diphenylphosphine) azophenlyene (3.7g, 6.7mmol), reactant mixture 105 DEG C stirring Reaction 10h, TLC point plate determines that reaction is complete, and reactant liquor is down to room temperature, filters, and filtrate concentrated by rotary evaporation, to dry, uses acetic acid second Ester and normal hexane mixed solvent recrystallization, obtain N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzo Imidazoles-5-Methanamide, off-white color solid (33.4g), yield 82.5%, the reaction equation of this step is with embodiment 1;
E) prepare than Buddhist nun for Buddhist nun:
N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide (33.0g, 0.07mol) it is dissolved in DMF (100mL), adds cesium carbonate (34.5g, 0.11mol), be cooled to-10 DEG C, Dropping iodomethane (12.1g, 0.09mol), reactant mixture 70 DEG C stirring reaction 4h, TLC point plate determines that reaction is complete, reaction Liquid is down to room temperature, and concentrated by rotary evaporation, to dry, adds ethyl acetate extraction, and magnesium sulfate is dried, and concentrated by rotary evaporation is the most dry, recrystallizing methanol, Obtain N-(tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide, then By the deprotection reaction step of patent WO2014063024, carry out deprotection reaction with phosphoric acid, through post processing and purification, Than Buddhist nun for Buddhist nun, off-white color solid (17.9g), yield 59.5%, the reaction equation of this step is with embodiment 1.
Embodiment 4
A) N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide is prepared:
2,3,4-tri-fluorine-5-nitro benzoic acid (36.0g, 0.16mol) and N, N '-dicyclohexylcarbodiimide (50.4g, 0.24mol) It is dissolved in toluene (200mL), stirring, add O-(2-t-butoxy ethyl) azanol (29.3g, 0.22mol), drip N, N-diformazan Aniline (90.8g, 0.75mol), reactant mixture 45 DEG C stirring reaction 12h, TLC point plate determines that reaction is complete, and reactant liquor revolves Steaming is concentrated to dryness, and adds dilute hydrochloric acid and regulates to neutral, adds ethyl acetate extraction, and magnesium sulfate is dried, and concentrated by rotary evaporation is the most dry, first Alcohol recrystallization, obtains the fluoro-5-nitrobenzamide of N-(2-tert-butoxyethoxy)-2,3,4-tri-, off-white color solid (48.0g), yield 87.6%, the reaction equation of this step is with embodiment 1;
B) N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide is prepared:
N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide (48.0g, 0.14mol) is dissolved in N-Methyl pyrrolidone (135mL), adding the ammonia (0.83mol) of mass percent concentration 28%, reactant mixture is placed in airtight stainless steel reaction At 85 DEG C, stirring reaction 8h under the pressure of 2.5 atmospheric pressure in still, after completion of the reaction, it is cooled to 40 DEG C and delivery systme pressure, It is slowly added to water (60mL), is cooled to 10 DEG C, crystallize 3h, filters, recrystallisation from isopropanol, obtains N-(2-tert-butoxy ethoxy Base)-2,4-diaminourea-3-fluoro-5-nitrobenzamide, off-white color solid (42.2g), yield 89.4%, the reaction equation of this step is same Embodiment 1;
C) N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide is prepared:
N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide (42.0g, 0.13mol), formic acid (105.4g, 2.29mol), the palladium dydroxide carbon (60.9g, 0.11mol) of noble metal mass percentage content 20% and isopropanol (600mL) Mixing, reactant mixture 95 DEG C stirring reaction 20h, TLC point plate determines that reaction is complete, and reactant liquor is down to room temperature, filters, rotation Steaming is concentrated to dryness, and with ethyl acetate and normal hexane mixed solvent recrystallization, obtains N-(2-tert-butoxyethoxy) the fluoro-3H-of-6-amino-7- Benzimidazole-5-Methanamide, off-white color solid (32.2g), yield 81.5%, the reaction equation of this step is with embodiment 1;
D) N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide is prepared:
N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide (32.0g, 0.10mol) is dissolved in N, N-bis- Methylformamide (350mL), add the bromo-2-of 4-fluoro-1-iodobenzene (43.4g, 0.14mol), cesium carbonate (92.4g, 0.28mol), Double (tri-butyl phosphine) palladium (2.0g, 3.9mmol), 4, double diphenylphosphine-9 of 5-, 9-dimethyl xanthene (4.5g, 7.7mol), reaction 110 DEG C of mixture stirring reaction 11h, TLC point plate determines that reaction is complete, and reactant liquor is down to room temperature, filters, filtrate concentrated by rotary evaporation To dry, with ethyl acetate and normal hexane mixed solvent recrystallization, obtain N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) ammonia Base]-7-fluoro-3H-benzimidazole-5-Methanamide, off-white color solid (40.0g), yield 80.0%, the reaction equation of this step is with implementing Example 1;
E) prepare than Buddhist nun for Buddhist nun:
N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide (40.0g, 0.08mol) it is dissolved in N,N-dimethylacetamide (130mL), adds potassium carbonate (19.4g, 0.14mol), be cooled to-10 DEG C, Dropping iodomethane (14.3g, 0.10mol), reactant mixture 55 DEG C stirring reaction 4h, TLC point plate determines that reaction is complete, reaction Liquid is down to room temperature, and concentrated by rotary evaporation, to dry, adds ethyl acetate extraction, and magnesium sulfate is dried, and concentrated by rotary evaporation is the most dry, recrystallizing methanol, Obtain N-(tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide, then By the deprotection reaction step of patent WO2014063024, carry out deprotection reaction with phosphoric acid, through post processing and purification, Than Buddhist nun for Buddhist nun, off-white color solid (20.3g), yield 55.5%, the reaction equation of this step is with embodiment 1.

Claims (10)

1. the synthetic method replacing Buddhist nun than Buddhist nun, it is characterised in that described method comprises the steps:
(1) N-(2-tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide is prepared: by 2,3,4-tri-fluorine-5-nitro benzoic acid In the system that condensing agent, acid binding agent alkali, solvent form, carry out condensation reaction with O-(2-t-butoxy ethyl) azanol, obtain N-(2- Tert-butoxyethoxy)-2,3,4-three fluoro-5-nitrobenzamide;
(2) N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide is prepared: by N-(2-tert-butoxy second Epoxide)-2,3,4-tri-fluoro-5-nitrobenzamides and ammonia carries out the aminating reaction that pressurizes in N-Methyl pyrrolidone, obtains N-(2- Tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide;
(3) N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide is prepared: by N-(2-tert-butoxy Ethyoxyl)-2,4-diaminourea-3-fluoro-5-nitrobenzamide and formic acid carries out cyclization at palladium dydroxide carbon in the system of solvent composition Reaction, obtains N-(2-tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide;
(4) N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide is prepared: By N-(2-the tert-butoxyethoxy)-6-amino-7-fluoro-3H-benzimidazole-5-Methanamide fluoro-1-iodobenzene of 2-bromo-with 4-at base reagent, urge The system of agent, complexant and solvent composition carries out substitution reaction, obtains N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorobenzene Base) amino]-7-fluoro-3H-benzimidazole-5-Methanamide;
(5) preparation replaces Buddhist nun than Buddhist nun: by N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole -5-Methanamide carries out methylation reaction at base reagent with iodomethane in the system of solvent composition, obtains N-(tert-butoxy ethoxy Base)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide, then by N-(tert-butoxy ethoxy Base)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3-methyl-3H-benzimidazole-5-Methanamide and phosphoric acid carries out deprotection reaction, obtains Than Buddhist nun for Buddhist nun.
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that the condensing agent described in step (1) For N, N '-carbonyl dimidazoles, 1-(3-dimethylamino-propyl)-3-ethyl carbodiimide, 1-hydroxy benzo triazole, N, N '-two hexamethylene Base carbodiimide or N, N '-DIC;Described acid binding agent alkali be N, N-diisopropylethylamine, triethylamine, two Ethamine, trimethylamine, pyridine, piperidines, DMAP, 2,6-lutidines, aniline, N, N-dimethylaniline, N, N- Diethylaniline, Tris(isopropylamine)., tri-n-butylamine, tetramethyl guanidine, N-methylmorpholine or N-ethylmorpholine;Described solvent is four Hydrogen furan, dichloromethane, 1,2-dichloroethanes, chloroform, chlorobenzene, acetonitrile, toluene, N,N-dimethylformamide, methyl-tert fourth Base ether or 1,4-dioxane;Wherein, 2,3,4-tri-fluorine-5-nitro benzoic acids, O-(2-t-butoxy ethyl) azanol, condensing agent, Mol ratio between acid binding agent alkali, solvent is 1.0: (1.1~1.5): (1.1~1.8): (3.5~5.5): (10.0~25.0).
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that the ammonia described in step (2) Mass percent concentration is 28%;Wherein, the fluoro-5-nitrobenzamide of N-(2-tert-butoxyethoxy)-2,3,4-tri-, ammonia, Mol ratio between N-Methyl pyrrolidone is 1.0: (5.5~6.5): (5.0~20.0).
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that the hydroxide described in step (3) The noble metal mass percentage content of palladium carbon is 20%;Described solvent is methanol, ethanol, the tert-butyl alcohol or isopropanol;Wherein, Rubbing between N-(2-tert-butoxyethoxy)-2,4-diaminourea-3-fluoro-5-nitrobenzamide, formic acid, palladium dydroxide carbon, solvent Your ratio is 1.0: (10~20): (0.5~1.0): (50.0~80.0).
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that the base reagent described in step (4) For cesium carbonate, potassium carbonate or sodium carbonate;Described catalyst is three (dibenzalacetone) two palladium or double (tri-butyl phosphine) palladium;Institute The complexant stated is the double diphenylphosphine-9,9-dimethyl xanthene of 4,5-, double (2-diphenylphosphine phenyl) ether or 4,6-bis-(diphenylphosphine) Azophenlyene;Described solvent is toluene, 1,4-dioxane or N,N-dimethylformamide;Wherein, N-(2-tert-butoxyethoxy)-6- Between amino-7-fluoro-3H-benzimidazole-5-Methanamide, the bromo-2-of 4-fluoro-1-iodobenzene, base reagent, catalyst, complexant, solvent Mol ratio is 1.0: (1.1~1.4): (2.2~2.8): (0.03~0.05): (0.06~0.1): (10.0~50.0).
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that the base reagent described in step (5) For potassium carbonate, sodium carbonate or cesium carbonate;Described solvent is N,N-dimethylformamide or DMAC N,N' dimethyl acetamide;Wherein, N-(2-tert-butoxyethoxy)-6-[(4-bromo-2-fluorophenyl) amino]-7-fluoro-3H-benzimidazole-5-Methanamide, iodomethane, base reagent, Mol ratio between solvent is 1.0: (1.1~1.3): (1.4~1.8): (15.0~30.0).
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that the condensation described in step (1) is anti- The temperature answered is 40~60 DEG C, and the response time is 4~12h.
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that step (2) described aminating reaction Pressure be 2~3 atmospheric pressure, reaction temperature is 70~90 DEG C, and the response time is 4~8h.
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that the cyclization described in step (3) is anti- The temperature answered is 65~100 DEG C, and the response time is 16~32h.
A kind of synthetic method replacing Buddhist nun than Buddhist nun the most according to claim 1, it is characterised in that the replacement described in step (4) is anti- The temperature answered is 90~110 DEG C, and the response time is 8~16h;The temperature of the methylation reaction described in step (5) is 50~75 DEG C, Response time is 1~4h.
CN201610303794.8A 2016-05-10 2016-05-10 A kind of synthetic method for replacing Buddhist nun than Buddhist nun Active CN105820124B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610303794.8A CN105820124B (en) 2016-05-10 2016-05-10 A kind of synthetic method for replacing Buddhist nun than Buddhist nun

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610303794.8A CN105820124B (en) 2016-05-10 2016-05-10 A kind of synthetic method for replacing Buddhist nun than Buddhist nun

Publications (2)

Publication Number Publication Date
CN105820124A true CN105820124A (en) 2016-08-03
CN105820124B CN105820124B (en) 2018-09-04

Family

ID=56528355

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610303794.8A Active CN105820124B (en) 2016-05-10 2016-05-10 A kind of synthetic method for replacing Buddhist nun than Buddhist nun

Country Status (1)

Country Link
CN (1) CN105820124B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905171A (en) * 2017-03-31 2017-06-30 浙江大学 The preparation method of 2 [2 tert-butoxyethoxy] ethamine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905171A (en) * 2017-03-31 2017-06-30 浙江大学 The preparation method of 2 [2 tert-butoxyethoxy] ethamine

Also Published As

Publication number Publication date
CN105820124B (en) 2018-09-04

Similar Documents

Publication Publication Date Title
CN104610250B (en) 1,2,3-thiadiazole-5-formamidine compound containing three N-heterocycles and synthesis
CN102584795B (en) Preparing method of crizotinib
CN105777710B (en) A kind of Ai Le replaces the synthetic method of Buddhist nun
CN105949135A (en) Synthetic method of selexipag
CN105801481A (en) Lenvatinib synthesizing method
CN105837502A (en) Synthesis method of Vadadustat
CN103570633B (en) The preparation method of Gefitinib
CN106146502A (en) End for Larry this synthetic method and prepare intermediate
CN104774194B (en) deuterated hepatitis c virus inhibitors
CN106543060A (en) It is a kind of it is difficult to understand this for Buddhist nun's mesylate preparation method
CN114315933B (en) Preparation method of potential anti-new coronavirus drug monatin
CN106045983A (en) Preparing method of Afatinib
CN103755648B (en) New impurity of a kind of Gefitinib and preparation method thereof
CN105820124A (en) Synthesizing method for binimetinib
EP4045494B1 (en) Synthesis of 6-methyl-n1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine
CN105273023B (en) A kind of preparation method of 5 '-O-L- valinate hydrochlorides of cytarabine
CN101376667B (en) Intermediate for synthesizing azidothimidine, preparation thereof and use in azidothimidine synthesis
WO2014180271A1 (en) Method for preparing afatinib and intermediate thereof
CN106146512B (en) The preparation method of Buddhist nun is replaced according to Shandong
CN114941018B (en) Synthesis method of cap1 cap analogue
CN103374049B (en) One prepares 5,6, the method for 4 '-trihydroxyflavone-7-0-D-glucuronic acid
CN103864877B (en) A kind of preparation method of Abiraterone acetate
CN105085595B (en) A kind of method of deacylation base protection 2,6 halosubstituted purine nucleosides of synthesis
CN101486749A (en) Method for synthesizing 4 alpha-amido-5 alpha- androstane-3,17-dione compound
CN103254156A (en) Preparation method of afatinib intermediate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 410329 No. 908 Kang Wan Road, Liuyang economic and Technological Development Zone, Changsha, Hunan

Applicant after: Hunan Eurasia Pharmaceutical Co., Ltd.

Address before: 410329 No. 908 Kang Wan Road, Liuyang Changsha National Bio Pharmaceutical Industrial Park, Changsha, Hunan

Applicant before: Hunan Ouya Biological Co., Ltd.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A synthetic method of binitinib

Effective date of registration: 20210430

Granted publication date: 20180904

Pledgee: Bank of Changsha Limited by Share Ltd. Liuyang branch

Pledgor: Hunan Eurasia pharmaceutcal Corp.,Ltd.

Registration number: Y2021430000009

PE01 Entry into force of the registration of the contract for pledge of patent right